Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions | Communications Biology
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia - Corbingi - 2020 - British Journal of Haematology - Wiley Online Library
Development of oligoclonal band (OB) in a patient with IgGκ myeloma... | Download Scientific Diagram
Pharmacokinetics of Monoclonal Antibodies - Ryman - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Frontiers | The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone - Kidney International
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS) Idiopathic Associated with other diseases (autoimmune, infectious, non-heme. - ppt download
Frontiers | Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis
Cloning of IgM cDNA and construction of various IgM/IgG chimeric... | Download Scientific Diagram
Abnormal immunoglobulins and immunoglobulin specificities (1)
Antibodies | Free Full-Text | Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers
Plasma cell myeloma expressing IgG heavy chain with co-expression of... | Download Scientific Diagram
Immunoglobulin germline gene variation and its impact on human disease | Genes & Immunity
Monoklonal gammopati av klinisk betydning | Tidsskrift for Den norske legeforening
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations - ScienceDirect
免疫グロブリン遊離鎖 κ/λ比
Frontiers | Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma